Sort
15,842 grants matching “pancreatic cancer”
Listeria Immunotherapy for Pancreatic and Ovarian Cancer
$503,783Cerus Corporation · R44 · FY2005 · CA
An Improved Red Blood Cell Storage Product and Extended Shelf Life using a Normoglycemic Additive Solution
$503,764Dana M Spence · Michigan State University · R01 · FY2023 · HL
Stage- & cell-specific targeting of RTK in tumorigenesis
$503,750Douglas Hanahan · University Of California, San Francisco · R01 · FY2007 · CA
Facilitated Education and Testing in BRCA Positive Families
$503,694Marc D Schwartz · Georgetown University · R01 · FY2020 · CA
Stage- & cell-specific targeting of RTK in tumorigenesis
$503,687Douglas Hanahan · University Of California, San Francisco · R01 · FY2006 · CA
Sialylation-dependent mechanisms driving pancreatic cancer progression
$503,659Susan L Bellis · University Of Alabama At Birmingham · U01 · FY2022 · CA
Role of RABL6A-PP2A in neuroendocrine tumors
$503,559Dawn E Quelle · University Of Iowa · R01 · FY2024 · CA
The Ohio State University Pancreatic Disorders Network (OSU-PDN)
$503,511Darwin Lewis Conwell · Ohio State University · U01 · FY2016 · DK
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer
$503,508Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2023 · CA
Optimizing Ultrasound Enhanced Delivery of Therapeutics
$503,459Flemming Forsberg · Thomas Jefferson University · R01 · FY2019 · CA
Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling
$503,421Michelle Christine Mendoza · University Of Utah · R01 · FY2023 · CA
Facilitated Education and Testing in BRCA Positive Families
$503,372Marc D Schwartz · Georgetown University · R01 · FY2021 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$502,945Elizabeth Mittendorf · Methodist Hospital Research Institute · U54 · FY2016 · CA
Mutant p53 in Tumorigenesis, Invasion, and Metastasis
$502,841Francisco Javier Sanchez-Rivera · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
$502,765David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
MR-HIFU induced drug delivery for pancreatic cancer treatment
$502,708Donghoon Lee · University Of Washington · R01 · FY2016 · CA
Project 1: Inhibition of Metastasis Utilizing Pharmacological Ascorbate in Pancreas Cancer
$502,555Joseph J Cullen · University Of Iowa · P01 · FY2022 · CA
The Role of Microbiome Modulation in Morphine-Induced Exacerbation of Pancreatitis
$501,885Sabita Roy · University Of Miami School Of Medicine · R01 · FY2020 · DK
The Role of Microbiome Modulation in Morphine-Induced Exacerbation of Pancreatitis
$501,885Ashok K Saluja · University Of Miami School Of Medicine · R01 · FY2018 · DK
The Role of Microbiome Modulation in Morphine-Induced Exacerbation of Pancreatitis
$501,885Sabita Roy · University Of Miami School Of Medicine · R01 · FY2021 · DK
The Role of Microbiome Modulation in Morphine-Induced Exacerbation of Pancreatitis
$501,885Ashok K Saluja · University Of Miami School Of Medicine · R01 · FY2019 · DK
Myofibroblasts in Gastrointestinal Cancers
$501,771Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2015 · CA
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$501,670Lingyin Li · Stanford University · R01 · FY2021 · CA
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
$501,426Timothy Patrick Spicer · Scripps Florida · R33 · FY2016 · CA
Mechanisms of the spliceosome protein SF3B1 and inhibitors
$501,161Melissa S Jurica · University Of California Santa Cruz · R01 · FY2020 · GM